Article
A novel polymorphism in CDC6 is associated with the decline in lung function of ex-smokers in COPD.
Biochemical and biophysical research communications - 17 Apr 2009
Takabatake Noriaki, Toriyama Sayumi, Igarashi Akira, Tokairin Yoshikane, Takeishi Yasuchika, Konta Tsuneo, Inoue Sumito, Abe Shuichi, Shibata Yoko, Kubota Isao
Abstract excerpt
The effect of smoking cessation on the rate of decline in lung function in patients with advanced stages of chronic obstructive pulmonary disease (COPD) has not been clarified. Saccharomyces cerevisiae cell division cycle 6 homolog (CDC6) protein possesses the pro-apoptotic properties. We tested our hypothesis that the individual susceptibility to rapid decline in lung function despite smoking cessation in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
